Medulloblastoma

Arsenic Trioxide Combined With Chemotherapy for Relapsed SHH-Activated and/or TP53-Mutant Medulloblastoma

Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors

Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease

Rare CNS Tumors Outcomes &Risk

Pharmacoscopy for Patients With Refractory Primary Brain Tumors

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults

PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma

B7-H3.CD28Z.CART in CNS Neoplasms

Digoxin Medulloblastoma Study

Parental Distress and Treatment Adherence in Pediatric Recurrent Medulloblastoma

Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers

Clinical Studies of Gemcitabine-Oxaliplatin

Phase I Study of APX005M in Pediatric Central Nervous System Tumors

Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor

DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications

Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma

Accurate Diagnosis and Grading of Pediatric Solid Tumors Based on Pathological Large Models

Atovaquone Combined With Radiation in Children With Malignant Brain Tumors